CNSP (STOCKS)
CNS Pharmaceuticals, Inc. Common Stock
$4.740000
-0.150000 (-3.07%)
Prev close: $4.890000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Rami Levin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7.04M
- Employees
- 4
- P/E (TTM)
- -0.16
- P/B (TTM)
- 56.12
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-7.30 | $-5.48 | -1.8226 | -33.27% |
|
Dec 2025 (Q4)
|
$-10.15 | $-5.19 | -4.9582 | -95.50% |
|
Sep 2025 (Q3)
|
$-5.76 | $-7.24 | +1.4769 | +20.41% |
|
Jun 2025 (Q2)
|
$-6.42 | $-9.79 | +3.3720 | +34.44% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $137.81K |
| Operating Expenses | $16.62M |
| Research and Development | $10.07M |
| Other Operating Expenses | $6.55M |
| Operating Income/Loss | -$16.62M |
| Income/Loss From Continuing Operations After Tax | -$16.49M |
| Income/Loss From Continuing Operations Before Tax | -$16.49M |
| Net Income/Loss | -$16.49M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$16.49M |
| Net Income/Loss Available To Common Stockholders, Basic | -$16.49M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$29.63 |
| Diluted Earnings Per Share | -$29.63 |
| Basic Average Shares | 1,661,988 |
| Diluted Average Shares | 1,661,988 |
| Assets | $4.65M |
| Current Assets | $4.08M |
| Noncurrent Assets | $574.85K |
| Fixed Assets | $22.01K |
| Non-current Prepaid Expenses | $552.84K |
| Liabilities | $4.58M |
| Current Liabilities | $4.58M |
| Noncurrent Liabilities | $0.00 |
| Equity | $70.71K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $70.71K |
| Liabilities And Equity | $4.65M |
| Net Cash Flow From Operating Activities | -$15.22M |
| Net Cash Flow From Operating Activities, Continuing | -$15.22M |
| Net Cash Flow From Investing Activities | $6.56M |
| Net Cash Flow From Investing Activities, Continuing | $6.56M |
| Net Cash Flow From Financing Activities | $5.15M |
| Net Cash Flow From Financing Activities, Continuing | $5.15M |
| Net Cash Flow | -$3.51M |
| Net Cash Flow, Continuing | -$3.51M |
| Comprehensive Income/Loss | -$16.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$16.49M |
| Other Comprehensive Income/Loss | $0.00 |